PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America dominates the global pharmaceutical excipients market, owing to large presence of major pharmaceutical companies in U.S. and Canada Developed healthcare infrastructure in North America boosts demand for pharma excipient. Key players like Dow, Ashland, BASF have their largest R&D and manufacturing facilities located in the region to cater to nearby pharmaceutical customers. Stringent regulations regarding drug production and quality standards enforced by U.S. FDA also compel American drug makers to source excipients locally from well-established suppliers in the region.

Asia Pacific region has emerged as the fastest growing market for pharmaceutical excipients globally. Rapid economic development, healthcare reforms, growing population and urbanization have tremendously boosted pharmaceutical market across countries like India, China, Japan, Australia. Many large domestic and multinational drug companies have setup or expanded production capacities in Asia to leverage the low manufacturing costs and huge potential of Asian patient pool. India has gained prominence as the global hub for generic drugs production, and Indian excipient manufacturers are suitably scaling up their capacities to match the rising local demand from domestic drug manufacturers. China also has become integral part of global pharma supply chain with high reliance on locally made excipients considering Beijing's policy initiatives for healthcare and biopharma industry. Other Asian countries are also witnessing increased local pharmaceutical production activities along with growing medical tourism that boosts demand for supporting excipient ingredients within the region.